$15.45
+12.78 (+478.65%)
Open$2.87
Previous Close$2.67
Day High$19.29
Day Low$2.75
52W High$1,281.00
52W Low—
Volume—
Avg Volume110.4K
Market Cap18.06M
P/E Ratio—
EPS$-370.63
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+210.0% upside
Current
$15.45
$15.45
Target
$47.90
$47.90
$35.39
$47.90 avg
$54.68
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.15B | 1.17B | 728.2K |
| Net Income | -5,342,220,413 | -4,869,352,209 | 171.9K |
| Profit Margin | -464.2% | -441.0% | 23.6% |
| EBITDA | -4,578,389,428 | -4,404,972,611 | 249.9K |
| Free Cash Flow | — | — | 132.1K |
| Rev Growth | -1.3% | -1.3% | -5.9% |
| Debt/Equity | 3.64 | 3.64 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |